![Di Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Di Yu is the founder of Elicera Therapeutics AB, founded in 2014, holding the title of Chief Scientific Officer since 2026.
Dr. Yu currently works at Uppsala Universitet Innovation Tools AB as an Associate Professor.
Dr. Yu completed a doctorate degree at the University of Uppsala and an undergraduate degree at Shaanxi Normal University.
Postes actifs de Di Yu
| Sociétés | Poste | Début |
|---|---|---|
| ELICERA THERAPEUTICS AB | Fondateur | 01/01/2014 |
Uppsala Universitet Innovation Tools AB | Corporate Officer/Principal | - |
Formation de Di Yu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shaanxi Normal University
 Shaanxi Normal University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uppsala Universitet Innovation Tools AB | |
Elicera Therapeutics AB
 Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
